Sheila Gujrathi insider trades: Ventyx Biosciences (VTYX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sheila reports to the SEC
and 2 more companies
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 23, 2024 | VTYX | ↑ Buy | 130,000 | $2.31 | $301K | Indirect | Dec 26, 2024 (3d) |
| Mar 30, 2023 | VTYX | ↓ Sell | 100,000 | $33.73 | $3.4M | Direct | Mar 31, 2023 (1d) |
| Sep 27, 2019 | GOSS | ↑ Buy | 10,000 | $16.80 | $168K | By family trust | Sep 27, 2019 (0d) |
| Nov 11, 2014 | RCPT | ↓ Sell | 30,000 | $108.99 | $3.3M | Direct | Nov 12, 2014 (1d) |
| Sep 22, 2014 | RCPT | ↓ Sell | 30,000 | $61.45 | $1.8M | Direct | Sep 24, 2014 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VTYX insiders
Open-market trades in the last 12 months
About Sheila Gujrathi's insider trades
Sheila Gujrathi is an insider at Ventyx Biosciences (VTYX). Since Sep 22, 2014, Sheila has reported 2 open-market purchases worth $469K and 3 sales worth $8.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (23 filings), other transactions (4 filings), conversions (3 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VTYX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.